The insecticide endosulfan and its two stereoisomers promote the growth of altered hepatic foci in rats.
The non-genotoxic, chlorinated cyclodiene insecticide endosulfan was studied for its ability to act as a tumour promoter in a two-stage, altered hepatic foci bioassay in male Sprague-Dawley rats. Two stereoisomers of endosulfan, alpha-endosulfan (ENDO alpha) and beta-endosulfan (ENDO beta) were used, as well as a commercially-occurring mixture of the alpha- and beta-isomers (ENDO alpha beta). The animals were initiated by intraperitoneal injection of nitrosodiethylamine 24 h after a two-thirds-partial hepatectomy. Five weeks later the animals were transferred to diets containing 30, 100 and 300 p.p.m. of either ENDO alpha beta, ENDO alpha or ENDO beta. The study was terminated 25 weeks after initiation and the development of foci of gamma-glutamyltranspeptidase-positive hepatocytes was evaluated by stereological methods. The results show that endosulfan and its two stereoisomers promote the development of altered hepatic foci, suggesting that endosulfan is a tumour-promoting agent acting by clonal expansion of initiated cells.